trial

Study of Vitamin D in the Severely Mentally Ill

NCTId NCT01169142
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 40 (actual)
Sponsored by Bronx Psychiatric Center
Primary completion 2014-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
40 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2010-01
Primary completion
2014-06
Eligibility
ALL · 19 Years · 70 Years

Interventions & indications

Drugs
Vitamin D3

Sponsors

Bronx Psychiatric CenterLead Sponsor

Investigators

1
Nigel Bark, MDPrincipal Investigator

Sites

1 total
The Bronx, United States

Facts & assertions

4 sourced
Enrollment
40
Phase
PHASE4
Primary Completion Date
2014-06
Status
COMPLETED
relationships
The graph out of here
drug
Vitamin D3
drug
lead_sponsor
Bronx Psychiatric Center
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Nigel Bark, MD
person